Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2020 - 2022)

Historic Liabilities from Discontinued Operations for Integra Lifesciences Holdings (IART) over the last 3 years, with Q2 2022 value amounting to $2.3 million.

  • Integra Lifesciences Holdings' Liabilities from Discontinued Operations changed N/A to $2.3 million in Q2 2022 from the same period last year, while for Jun 2022 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $11.8 million for FY2020, which is N/A changed from last year.
  • According to the latest figures from Q2 2022, Integra Lifesciences Holdings' Liabilities from Discontinued Operations is $2.3 million.
  • In the past 5 years, Integra Lifesciences Holdings' Liabilities from Discontinued Operations ranged from a high of $12.3 million in Q3 2020 and a low of $2.3 million during Q2 2022